263 related articles for article (PubMed ID: 30155722)
1. In vitro assessment of hepatotoxicity by metabolomics: a review.
Cuykx M; Rodrigues RM; Laukens K; Vanhaecke T; Covaci A
Arch Toxicol; 2018 Oct; 92(10):3007-3029. PubMed ID: 30155722
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics profiling of steatosis progression in HepaRG
Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
[TBL] [Abstract][Full Text] [Related]
3. Analysis of extracellular metabolome by HS-SPME/GC-MS: Optimization and application in a pilot study to evaluate galactosamine-induced hepatotoxicity.
Araújo AM; Moreira N; Lima AR; Bastos ML; Carvalho F; Carvalho M; Guedes de Pinho P
Toxicol Lett; 2018 Oct; 295():22-31. PubMed ID: 29852275
[TBL] [Abstract][Full Text] [Related]
4. Hepatoxicity mechanism of cantharidin-induced liver LO2 cells by LC-MS metabolomics combined traditional approaches.
Liu F; Wang X; Duan C; Zhang J; Li X
Toxicol Lett; 2020 Oct; 333():49-61. PubMed ID: 32726682
[TBL] [Abstract][Full Text] [Related]
5. An in vitro metabolomics approach to identify hepatotoxicity biomarkers in human L02 liver cells treated with pekinenal, a natural compound.
Shi J; Zhou J; Ma H; Guo H; Ni Z; Duan J; Tao W; Qian D
Anal Bioanal Chem; 2016 Feb; 408(5):1413-24. PubMed ID: 26715247
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs.
Li Y; Wang L; Ju L; Deng H; Zhang Z; Hou Z; Xie J; Wang Y; Zhang Y
Toxicol Sci; 2016 Apr; 150(2):390-9. PubMed ID: 26781514
[TBL] [Abstract][Full Text] [Related]
7. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
8. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
[TBL] [Abstract][Full Text] [Related]
9. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
11. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
12.
Huo T; Fang Y; Zhao L; Xiong Z; Zhang Y; Wang Y; Feng C; Yuan M; Wang S; Chen M; Jiang H
J Ethnopharmacol; 2016 Nov; 192():1-9. PubMed ID: 27377338
[TBL] [Abstract][Full Text] [Related]
13. The use of hepatocytes to investigate drug toxicity.
Gómez-Lechón MJ; Castell JV; Donato MT
Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits.
Xue LM; Zhang QY; Han P; Jiang YP; Yan RD; Wang Y; Rahman K; Jia M; Han T; Qin LP
J Ethnopharmacol; 2014 Mar; 152(2):272-82. PubMed ID: 24447814
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
Beger RD; Sun J; Schnackenberg LK
Toxicol Appl Pharmacol; 2010 Mar; 243(2):154-66. PubMed ID: 19932708
[TBL] [Abstract][Full Text] [Related]
16. A single-injection targeted metabolomics profiling method for determination of biomarkers to reflect tripterygium glycosides efficacy and toxicity.
Hu T; Shi C; Liu L; Li P; Sun Y; An Z
Toxicol Appl Pharmacol; 2020 Jan; 389():114880. PubMed ID: 31945383
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of potential hepatotoxicity induced by drugs.
Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolomics study of the hepatoprotective effect of glycyrrhetinic acid on realgar-induced sub-chronic hepatotoxicity in mice via
Huo T; Fang Y; Zhang Y; Wang Y; Feng C; Yuan M; Wang S; Chen M; Jiang H
J Ethnopharmacol; 2017 Aug; 208():36-43. PubMed ID: 28673699
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
Mattes W; Davis K; Fabian E; Greenhaw J; Herold M; Looser R; Mellert W; Groeters S; Marxfeld H; Moeller N; Montoya-Parra G; Prokoudine A; van Ravenzwaay B; Strauss V; Walk T; Kamp H
Toxicol Lett; 2014 Nov; 230(3):467-78. PubMed ID: 25086301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
